Beximco Pharmaceuticals Ltd.

New product launches in 2016

Beximco Pharmaceuticals Ltd. (BPL), a leading pharmaceutical in Bangladesh having global footprint across 54 countries with its prescription medicine. Beximco pharma is a forefront in bringing new technology and generic has launched 20 products in 2016 across Cardiovascular, Endocrine Disorders, Antibiotics, Anti-viral, Respiratory and Ophthalmic portfolios. On 4 August 2016, Beximco Pharmaceuticals reached a new high became the first Bangladeshi Pharmaceutical Company to export Carvedilol to the United States of America.


Carvedilol Tablet

Carvedilol is a nonselective β-adrenergic blocking agent with α-blocking activity. It is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization. Carvedilol tablet is not approved for use in children under 18 years of age.
Carvedilol tablets are available as following strengths: 3.125 mg, 6.25 mg 12.5 mg and 25 mg tablets.

Now available in US Market



Ribavirin 200mg capsule
Viracin® is the preparation of ribavirin 200 mg capsule. It is a nucleoside analogue indicated in combination with interferon alfa-2b (pegylated and nonpegylated) for the treatment of Chronic Hepatitis C (CHC) in patients 3 years of age or older with compensated liver disease. Ribavirin has teratogenic effect. Pregnancy should be avoided during and for 6 months after treatment in both female patients and the female partners of male patients treated with ribavirin.


Daclatasvir 60 mg tablet
Dakovir-C® is the preparation of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir with or without rivabirin for the treatment of chronic HCV genotype 1 or 3 infection. With the Dakovir-C® Beximco now offer full range of oral treatment for chronic HCV including Lesovir-C® tablet (ledipasvir 90mg / Sofosbuvir 400mg), Sofovir-C® tablet (Sofosbuvir 400mg) and viracin capsule (ribavirin 200mg)



(Amoxicillin / Clavulanate Potassium)
Powder for suspension: 100 ml (125 mg Amoxicillin /31.25 mg K Clavulanate Potassium / 5 ml)
BID suspension: 50 ml (400 mg Amoxicillin /57 mg Clavulanate Potassium /5ml)
Injection: 500 mg Amoxicillin /100 mg Clavulanate Potassium /vial; 1000 mg Amoxicillin / 200 mg Clavulanate Potassium /vial
Tyclav® (Clavulanate-potentiated Amoxicillin) is a broad spectrum bactericidal antibiotic effective against the commonly occurring bacterial pathogens in general practices and hospitals. The beta-lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin Amoxicillin embrace a wider range of organisms, including many resistant ones to other beta-lactam antibiotics.


Cefuroxime (as cefuroxime axetil) 125mg/5ml
Powder for suspension
Turbocef® oral suspension is a preparation of cefuroxime axetil. Cefuroxime axetil is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration.
Turbocef® oral suspension is indicated for the treatment of mild to moderately severe infections caused by susceptible strains of the designated organisms.

Hormones & Steroids


Dienogest 2 mg tablet
Endometriosis is a chronic disease primarily affecting women of childbearing age, typically leading to painful symptoms, fatigue, and infertility. The symptoms of endometriosis may cause significant impairment in quality of life. Beximco is proud to announce 1st time launching of Dienogest (Dinogest) in Bangladesh to alleviate the condition. Dienogest is a progestogen-only hormone preparation for the treatment of endometriosis. It works by suppressing oestradiol production and preventing the growth of the endometrium. The recommended dose of dienogest is 2 mg taken by mouth once daily. This medication should be taken at the same time every day, if possible.


Prednisolone 5mg, 10 mg & 20 mg Tablet
Prednisolone is a corticosteroid drug with predominant glucocorticoid & low mineralocorticoid activity. Bexipred® is indicated for:

  • as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation
  • for the treatment of certain endocrine conditions
  • for palliation of certain neoplastic conditions (Hematologic disorders: Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erythroblastopenia (RBC anemia), congenital (erythroid) hypoplastic anemia.

Endocrine & Diabetes

Diapro® 60 MR

Gliclazide 60 mg Modified Release Tablet
Diapro® is an oral blood glucose lowering drug of the sulfonylurea class. It is indicated to treat patients with type 2 diabetes mellitus. The primary mechanism of action of Diapro® is lowering of blood glucose by stimulating the release of insulin from functioning pancreatic beta cells. In addition, expancreatic effects may also play vital role in the activity of Diapro®. Administration of Diapro® can lead to increase sensitivity of peripheral tissues to insulin. Diapro® 60 modified release (MR) is given once daily


Voglibose 0.2mg, 0.3 mg tablet
Beximco is pioneer in anti-diabetic portfolio has launched voglibose 1st time in Bangladesh under the brand name Vibose®. Voglibose acts by inhibition of alpha- glucosidase, an enzyme responsible to breakdown carbohydrate and facilitate the absorption of monosaccharide, i.e. glucose, fructose. Thus, voglibose delays the absorption as well as digestion of dietary polysaccharides. Voglibose is indicated for improvement of postprandial hyperglycemia in diabetes mellitus only when diet and/or exercise or oral hyperglycemic drug or Insulin preparation in addition to diet and/or exercise does not result in adequate glycemic (Glycemic) control. The drug is taken just before meals.


Azmasol® Respules

Salbutamol 2.5mg/3ml
Azmasol respules is a preparation of salbutamol comes as a solution (liquid) to inhale by mouth using nebulizer. Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction.
Azmasol® Respules are indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy, and in the treatment of acute severe asthma. Azmasol® Respules having 3ml solution do not require further dilution and present easy to use as nebulization.

Iprasol® Respules

Ipratropium bromide 0.5mg and Salbutamol 2.5mg/3ml
Iprasol® Respules is a combination of the beta2-adrenergic bronchodilator, salbutamol sulphate, and the anticholinergic bronchodilator, ipratropium bromide.
Iprasol® Respules are indicated in patients with COPD on a regular aerosol bronchodilator, who continue to have evidence of bronchospasm and who require a second bronchodilator. As the content is 3ml Iprasol® Respules solution do not require further dilution.

Ipramid® Respules

Ipratropium bromide 0.5mg/2.5ml
Ipratropium Bromide respiratory solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Onriva® Bexicap

Indacaterol 150mcg powder for inhalation capsule
Onriva is a long-acting beta2-adrenergic agonist indicated for:
The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Do not swallow the capsule. The medicine is to be taken with Bexihaler® device as instructed in product insert.


Doxofylline 400mg Tablet
Doxofylline 100mg/5ml Syrup
Fixolin® is the preparation of Doxofylline, a novel xanthine bronchodilator. The mechanism of action is similar to that of theophylline. Fixolin® is indicated to relief of bronchospasm in reversible airways obstruction eg, asthma and chronic obstructive pulmonary disease (COPD). Doxofylline has an extended bronchodilator action and contrasting theophylline it has slightest adenosine connections i.e., no CNS as well as CVS adverse reactions. There are no sleep troubles and no influences on gastric emissions with Fixolin® (Doxofylline). It is in addition extremely safe and sound in smokers.



Loteprednol Etabonate ophthalmic suspension 0.5%
Lacrison® (loteprednol etabonate ophthalmic suspension) 0.5% contains a sterile, topical corticosteroid for ophthalmic use. Lacrison® is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.

Lacrison® T

loteprednol etabonate and tobramycin ophthalmic suspension, 0.5%/0.3%
Lacrison® T is a topical anti-infective and steroid combination for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Vitamins & Minerals Supplement


Cholecalciferol 40000 IU capsule
Cholecalciferol 20000 IU capsule
Cholecalciferol 2000 IU Tablet
D-Rise® is the preparation of Cholecalciferol (Vitamin D3) presenting 40,000 IU and 20,000 IU capsules and 2000 IU tablets. Cholecalciferol is a form of Vitamin D which is synthesized only when our skin gets exposed to the sunlight. For this reason, Cholecalciferol is referred as “sunshine vitamin”. This vitamin is very essential for healthy body functioning.
D-Rise® is used for the prevention and treatment of Vitamin D deficiency symptoms including muscle weakness or muscle pain, joint pain, bone pain, mood swing, depression, dizziness and even osteomalacia or osteoporosis.